RIPE-KG · Version 1.1.0 · Resource
ripekg:author/RIPEAU3FF7BB838D14EAB5
https://w3id.org/ripe/ripe-kg/author/RIPEAU3FF7BB838D14EAB5
| Subject | Predicate | Object |
|---|---|---|
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
rdf:type |
node1 |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
rdf:type |
prov:Person |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
foaf:familyName |
Kanoko |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
foaf:givenName |
Tomohiro |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
foaf:name |
Tomohiro Kanoko |
ripekg:retraction-notice/10303Risedronate Therapy for Prevention of Hip Fracture After Stroke in Elderly Women. Reply to Authors |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/10309Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/11839Beneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/12296Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/16226Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer’s disease |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/16920Beneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/16986Cardiac Involvement in Malignant Syndrome in Parkinson’s Disease |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/17474Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/19309Abnormal calcium homeostasis in disabled stroke patients with low 25-hydroxyvitamin D |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/19310Homocysteine as a predictive factor for hip fracture in stroke patients |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/19830Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/20167Vitamin K Deficiency and Osteopenia in Elderly Women With Alzheimer's Disease |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/24589Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/4480Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/49930Risk factors for hip fracture among elderly patients with Alzheimer's disease |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/50213Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/5729The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: A randomized controlled trial |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/6555Risedronate Therapy for Prevention of Hip Fracture After Stroke in Elderly Women |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/9558Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:work/RIPEWB74E64550C4E8B60Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke |
dcterms:creator |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |